Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
D000328:Adult; D000450:Aldosterone / Q000097:blood*; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011187:Posture; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000378:metabolism; D013722:Teprotide / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D000450:Aldosterone; D012964:Sodium; D013722:Teprotide; D012083:Renin